Anti-Glucose Transporter GLUT1抗体[SPM498] (ab40084)

发表研究结果有使用 ab40084?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab40084 被引用在 25 文献中.

  • Henning Y & Szafranski K Age-Dependent Changes of Monocarboxylate Transporter 8 Availability in the Postnatal Murine Retina. Front Cell Neurosci 10:205 (2016). IHC-Fr ; Mouse . PubMed: 27616981
  • Bourseau-Guilmain E  et al. Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. Nat Commun 7:11371 (2016). IHC-Fr . PubMed: 27094744
  • Ramratnam M  et al. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J Am Heart Assoc 3:N/A (2014). PubMed: 25092788
  • Eilertsen M  et al. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival. PLoS One 9:e105038 (2014). IHC-P ; Human . PubMed: 25225794
  • Chang S  et al. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations. Pathol Int 64:607-12 (2014). PubMed: 25376377
  • Hegedus A  et al. HIV-1 pathogenicity and virion production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 11:98 (2014). Flow Cyt . PubMed: 25421745
  • Vaughan RA  et al. ß-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Mol Cancer 13:14 (2014). Flow Cyt, ICC/IF ; Human . PubMed: 24460609
  • Ganapathy S  et al. A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protection. J Biol Chem 289:5340-7 (2014). WB ; Human . PubMed: 24391088
  • Bravo-Nuevo A  et al. Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. PLoS One 9:e90031 (2014). WB ; Mouse . PubMed: 24587200
  • Freemerman AJ  et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem 289:7884-96 (2014). WB ; Rat . PubMed: 24492615
  • Kim S  et al. The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma. J Breast Cancer 16:146-51 (2013). IHC-P ; Human . PubMed: 23843845
  • Longati P  et al. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer 13:95 (2013). WB ; Human . PubMed: 23446043
  • Sorrentino NC  et al. A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. EMBO Mol Med 5:675-90 (2013). IHC-Fr ; Mouse . PubMed: 23568409
  • Morato PN  et al. Whey protein hydrolysate increases translocation of GLUT-4 to the plasma membrane independent of insulin in wistar rats. PLoS One 8:e71134 (2013). WB . PubMed: 24023607
  • Cioffi S  et al. Tbx1 regulates brain vascularization. Hum Mol Genet N/A:N/A (2013). PubMed: 23945394
  • Pyla R  et al. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells. Am J Physiol Cell Physiol 304:C574-89 (2013). PubMed: 23302780
  • Smeland E  et al. Prognostic impacts of hypoxic markers in soft tissue sarcoma. Sarcoma 2012:541650 (2012). IHC-P ; Human . PubMed: 22454562
  • Jun YJ  et al. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol 17:1866-73 (2011). IHC-P ; Human . PubMed: 21528061
  • Andersen S  et al. Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Lung Cancer 72:294-302 (2011). PubMed: 21075472
  • Merlini M  et al. Vascular ß-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAß mice. Acta Neuropathol 122:293-311 (2011). IHC-FoFr ; Mouse . PubMed: 21688176
  • Hasselbalch B  et al. Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. APMIS 118:585-94 (2010). IHC-P ; Human . PubMed: 20666740
  • Banerjee SK  et al. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 49:683-92 (2010). WB ; Mouse . PubMed: 20600102
  • Xiao C  et al. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem 285:36776-84 (2010). WB, IHC-P ; Mouse . PubMed: 20847051
  • Svensson KJ  et al. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase. Cancer Res 68:9291-301 (2008). IHC-P, IF ; Human . PubMed: 19010902
  • Khan ZA  et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592-9 (2008). IHC-P ; Human . PubMed: 18535669